Clinical Trial Update: Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating the combination of VA with the HAAG regimen in adults with newly diagnosed intermediate- or high-risk …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• HAAG regimen
• VA

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Intermediate Risk Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING